{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T08:26:54Z","timestamp":1782894414015,"version":"3.54.5"},"reference-count":26,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2016,10,24]],"date-time":"2016-10-24T00:00:00Z","timestamp":1477267200000},"content-version":"vor","delay-in-days":297,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"name":"Pfizer Japan Inc."}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Hypertension"],"published-print":{"date-parts":[[2016,1]]},"abstract":"<jats:p>Prospective postmarketing surveillance of Selara (eplerenone), a selective mineralocorticoid receptor antagonist, was performed to confirm its safety and efficacy for hypertension treatment in Japan. The change in blood pressure after initiation of eplerenone treatment was also examined. Patients with essential hypertension who were eplerenone\u2010na\u00efve were recruited regardless of the use of other antihypertensive drugs. For examination of changes in blood pressure, patients were excluded if eplerenone was contraindicated or used off\u2010label. Patients received 50\u2013100\u2009mg of eplerenone once daily and were observed for 12 weeks. No treatments including antihypertensive drugs were restricted during the surveillance period. Across Japan, 3,166 patients were included for safety analysis. The incidence of adverse drug reactions was 2.4%. The major adverse drug reactions observed were hyperkalemia (0.6%), dizziness, renal impairment, and increased serum potassium (0.2% each). The mean systolic blood pressure decreased from 152.1 \u00b1 19.0\u2009mmHg to 134.8 \u00b1 15.2\u2009mmHg at week 12, and the mean diastolic blood pressure decreased from 85.8 \u00b1 13.7\u2009mmHg to 77.7 \u00b1 11.4\u2009mmHg. There were no significant new findings regarding the type or incidence of adverse reactions, and eplerenone had a clinically significant antihypertensive effect, leading to favorable blood pressure control.<\/jats:p>","DOI":"10.1155\/2016\/5091951","type":"journal-article","created":{"date-parts":[[2016,10,24]],"date-time":"2016-10-24T17:03:24Z","timestamp":1477328604000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Safety and Antihypertensive Effect of Selara\u00ae (Eplerenone): Results from a Postmarketing Surveillance in Japan"],"prefix":"10.1155","volume":"2016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4050-8100","authenticated-orcid":false,"given":"Shoko","family":"Takahashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9229-3354","authenticated-orcid":false,"given":"Megumi","family":"Hiramatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5667-3990","authenticated-orcid":false,"given":"Shinichi","family":"Hotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8713-9456","authenticated-orcid":false,"given":"Yukie","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Suga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2006-7707","authenticated-orcid":false,"given":"Yutaka","family":"Endo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9362-8395","authenticated-orcid":false,"given":"Isamu","family":"Miyamori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,10,24]]},"reference":[{"key":"e_1_2_8_1_2","unstructured":"Office of Nutrition Cancer Measures and Health Promotion Division Health Service Ministry of Health Labour and Welfare Japan 2013 http:\/\/www.mhlw.go.jp\/bunya\/kenkou\/eiyou\/dl\/h25-houkoku.pdf."},{"key":"e_1_2_8_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/hr.2014.20"},{"key":"e_1_2_8_3_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.284427"},{"key":"e_1_2_8_4_2","doi-asserted-by":"publisher","DOI":"10.1161\/hyp.0000000000000003"},{"key":"e_1_2_8_5_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/eht151"},{"key":"e_1_2_8_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2015.05.127"},{"key":"e_1_2_8_7_2","volume-title":"Selara\u00ae Tablets 25\u2009mg, Selara\u00ae Tablets 50\u2009mg, Selara\u00ae Tablets 100\u2009mg","author":"Selara"},{"key":"e_1_2_8_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/hr.2008.18"},{"key":"e_1_2_8_9_2","first-page":"1034","article-title":"Special issue: clinical practice guidebook for diagnosis and treatment of chronic kidney disease 2012","volume":"54","author":"Japan Nephrology Society","year":"2012","journal-title":"Nihon Jinzo Gakkai Shi"},{"key":"e_1_2_8_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-4731(81)90046-7"},{"key":"e_1_2_8_11_2","doi-asserted-by":"publisher","DOI":"10.1210\/endo-125-4-2224"},{"key":"e_1_2_8_12_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.71.3.503"},{"key":"e_1_2_8_13_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.92.2.175"},{"key":"e_1_2_8_14_2","first-page":"41","article-title":"Identification and role of aldosterone receptors in the cardiovascular system","volume":"61","author":"Lomb\u00e8s M.","year":"2000","journal-title":"Annales d\u2032Endocrinologie"},{"key":"e_1_2_8_15_2","doi-asserted-by":"publisher","DOI":"10.1210\/en.2005-1244"},{"key":"e_1_2_8_16_2","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.29.627"},{"key":"e_1_2_8_17_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2003.00929.x"},{"key":"e_1_2_8_18_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.0000118519.66430.22"},{"key":"e_1_2_8_19_2","doi-asserted-by":"publisher","DOI":"10.1681\/asn.2011070734"},{"key":"e_1_2_8_20_2","doi-asserted-by":"publisher","DOI":"10.1097\/hjh.0b013e3280112ce5"},{"key":"e_1_2_8_21_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2005-870240"},{"key":"e_1_2_8_22_2","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvp191"},{"key":"e_1_2_8_23_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-2521"},{"key":"e_1_2_8_24_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-0736"},{"key":"e_1_2_8_25_2","doi-asserted-by":"publisher","DOI":"10.1111\/jch.12860"},{"key":"e_1_2_8_26_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00424-014-1658-0"}],"container-title":["International Journal of Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1155\/2016\/5091951","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1155\/2016\/5091951","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1155\/2016\/5091951","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T20:39:03Z","timestamp":1782851943000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1155\/2016\/5091951"}},"subtitle":[],"editor":[{"given":"Kazuomi","family":"Kario","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["10.1155\/2016\/5091951"],"URL":"https:\/\/doi.org\/10.1155\/2016\/5091951","archive":["Portico"],"relation":{},"ISSN":["2090-0384","2090-0392"],"issn-type":[{"value":"2090-0384","type":"print"},{"value":"2090-0392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"2016-05-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-07-05","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-10-24","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"5091951"}}